Global Vagus Nerve Stimulator Market Size, Trends & Growth Opportunity, By Product Type (Implantable VNS Devices, and External VNS Devices), By Biomaterial (Ceramics, Metallic, and Polymerics), By Application (Depression, Epilepsy, and Migraine), By End U

Global Vagus Nerve Stimulator Market Size, Trends & Growth Opportunity, By Product Type (Implantable VNS Devices, and External VNS Devices), By Biomaterial (Ceramics, Metallic, and Polymerics), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), Regional Outlook, Competitive Market Share, & Forecast, 2022–2027.

Global Vagus Nerve Stimulator Market

Global Vagus Nerve Stimulator Market was valued at USD 555.2 million in 2021 and is expected to reach USD 1195.9 million by 2027, at a CAGR of 12.15% from 2022 to 2027.

Vagus nerve stimulation (VNS) is a medical treatment which involves delivering electrical impulses to the vagus nerve. It uses an implanted device to send an electrical pulse to one’s vagus nerve, which then travels to one’s brain. Vagus nerve stimulators are also called vagus nerve stimulation. Surgeons implant a device near the collarbone and run a wire to the vagus nerve. When the device fires, it stimulates that nerve to send signals to the brain. This increases activity in areas that control mood.

Market Drivers

The rising prevalence of neurological disorders is the key factor expected to drive the global vagus nerve stimulator market growth. Also, increases in investments in the pharmaceutical and biotechnology industries and in research and development activities will have a positive impact on market growth.

Moreover, growing technological advancements and increase in prevalence of neurological disorders such as epilepsy, depression, anxiety, and others is expected to boost growth of the global vagus nerve stimulators market over the forecast period 2027.

Market Restraints

The lack of skilled professionals is the major challenging factor which is expected to obstruct the global vagus nerve stimulator market growth. High costs associated with neurostimulator devices are also expected to hinder the market growth.

Market Segmentation

The Global Vagus Nerve Stimulator Market is segmented into product, biomaterial, application, end user, and region.

Based on biomaterial, the Vagus Nerve Stimulator market is segmented into polymeric, metallic, and ceramic biomaterials. The polymeric segment is expected to advance at the highest growth rate of 2022 to 2037, owing to its flexibility benefits.

Regional Analysis

Global Vagus Nerve Stimulator Market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

The North American region dominates the vagus nerve stimulation market, owing to the growing government funding and initiatives for raising awareness about epilepsy and difficult-to-treat depression in the region. Also, rapid technological advancements, key manufacturers in the region are among the key factors expected to create significant growth opportunities in the North American market.

Key Players

Various key players are discussed in the Global Vagus Nerve Stimulator Market Report, including: Medtronic Plc, Nevro Corporation, EnteroMedics Inc., Bioness Inc., BioControl Medical, Aleva Neurotherapeutics SA, Boston Scientific Corporation, LivaNova Plc, ElectroCore LLC, and NeuroPace Inc.

For instance, in March 2020, LivaNova received CE Mark approval for their VNS Therapy System, Symmetry, for difficult-to-treat depression. Such key players operating in the industry are increasingly focusing on technological advancements, product launches, and other growth strategies, such as mergers and acquisitions, to strengthen their foothold in the market.

Market Taxonomy

By Product Type

• Implantable VNS Devices
• External VNS devices

• Ceramics
• Metallic
• Polymerics

• Depression
• Epilepsy
• Migraine

• Hospitals
• Ambulatory Surgical Centers
• Others

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa